Answers are grounded in this paper and cite their sources.
Psidium guajava (L.) is a medicinal plant rich in bioactive phytochemicals with promising therapeutic potential. This study aimed to isolate clerodane-type diterpenes from P. guajava and evaluate their anticancer activity through in vitro and in vivo assays supported by molecular docking.Two clerodane-type diterpenes, borapetoside F ( 1 ) and borapetoside B (2 ), were isolated from the ethyl acetate fraction of P. guajava and identified by 1 H and 13 C NMR spectroscopy. Cytotoxicity was evaluated against Ehrlich Ascites Carcinoma (EAC) cells using the MTT assay and in EAC-bearing Swiss albino mice, with bleomycin as the reference drug. Apoptosis was assessed by microscopy, DNA fragmentation, gene expression analysis. Compounds 1 and 2 demonstrated significant in vitro cytotoxicity, inhibiting EAC cell growth by 82.4% and 79.8%, respectively. In in vivo cytotoxicity assays, these compounds suppressed EAC cell proliferation by 61.26% and 48.88%, respectively. Optical and fluorescence microscopy revealed characteristic apoptotic morphological changes, while DNA fragmentation analysis confirmed apoptosis induction. Gene expression analysis demonstrated upregulation of the pro-apoptotic markers p53, Bax, and Cytochrome C, accompanied by downregulation of the anti-apoptotic genes Bcl-2 and NF-κB. Molecular docking further supported the experimental findings by demonstrating favorable interactions of both compounds with apoptosis-related target proteins. Collectively,. Borapetoside F ( 1 ) and borapetoside B ( 2 ) exhibit significant anticancer activity by inhibiting EAC cell proliferation and inducing apoptosis, suggesting their potential as promising lead compounds for anticancer drug development.
No takes yet. Share an insight, caveat, or question.
Khatun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: